"Rethinking SSRIs: A Critical Look at Long-Term Use, Efficacy, and Impact" challenges the widespread practice of prescribing Selective Serotonin Reuptake Inhibitors (SSRIs) for long periods, highlighting that there is limited long-term research supporting their extended efficacy. We scrutinize the persistent "chemical imbalance theory" as a "damaging myth" that often obscures the deeper roles of trauma and relational dynamics in mental distress. Furthermore, we highlight significant, yet underrecognized, consequences of chronic use, such as emotional blunting and the common misinterpretation of withdrawal symptoms as disease relapse, which can lead to inappropriate polypharmacy. Ultimately, advocating for a shift toward trauma-informed care and therapeutic modalities that prioritize genuine emotional healing and integration over indefinite symptom suppression.